Company page

Hutchmed (china) Limited

Hutchmed (China) Limited, trading under the ticker 13 on the Hong Kong Stock Exchange, has a market capitalization of approximately HKD 1.83 billion. The company focuses on the development and commercialization of innovative medicines for cancer and other critical diseases. Hutchmed aims to address unmet medical needs in China and globally through its research and development efforts.